Low INR with Low Prothrombin and Prolonged aPTT: Diagnostic Interpretation
This coagulation pattern most likely indicates a common pathway factor deficiency (Factor II, V, X, or fibrinogen), though the "low prothrombin" terminology requires clarification as it may refer to Factor II deficiency specifically or be a misinterpretation of prothrombin time results.
Understanding the Pattern
When both PT/INR and aPTT are abnormal, the defect localizes to the common pathway of coagulation, which includes:
- Factor II (prothrombin)
- Factor V
- Factor X
- Fibrinogen
The key distinction here is that a truly "low INR" (below normal range, typically <0.8) is extremely rare and suggests either laboratory error or pre-analytical issues. More commonly, clinicians may be describing a prolonged PT (which increases INR) alongside prolonged aPTT 1.
Diagnostic Algorithm
Step 1: Verify the Results
- Confirm the INR is actually low (not prolonged PT being misinterpreted)
- Rule out pre-analytical errors: improper sample collection, underfilled tubes, or delayed processing
- Repeat testing if values seem discordant
Step 2: Perform Mixing Study
Mix patient plasma 1:1 with normal pooled plasma and repeat PT/aPTT 1:
- If corrected: Factor deficiency is present
- If not corrected: Factor inhibitor or lupus anticoagulant present 2, 3
Step 3: Identify Specific Factor Deficiency
If mixing study corrects, measure specific factor activities 1:
- Factor II (prothrombin): <30% activity indicates deficiency
- Factor V: Not vitamin K-dependent
- Factor X: Vitamin K-dependent
- Fibrinogen: <150 mg/dL via Clauss method 4
Step 4: Determine Underlying Cause
Common pathway deficiencies result from:
Vitamin K deficiency: Affects Factors II, VII, IX, X (all vitamin K-dependent) 1, 3
- Look for: malnutrition, malabsorption, prolonged antibiotic use, lack of dietary intake
Liver disease: Impaired synthesis of all coagulation factors except Factor VIII 3
- Look for: jaundice, ascites, elevated liver enzymes, history of cirrhosis
Warfarin/oral anticoagulants: Inhibits vitamin K-dependent factors 1, 5
- Verify medication history
Disseminated intravascular coagulation (DIC): Consumption of multiple factors 3
- Look for: sepsis, thrombocytopenia, elevated D-dimer, low fibrinogen
Inherited factor deficiencies: Rare, usually present with lifelong bleeding history 4
Critical Clinical Considerations
Bleeding risk assessment depends on the specific factor levels 4:
- Factor activity <30%: Significant bleeding risk
- Factor activity 30-50%: Moderate risk, procedure-dependent
- Factor activity >50%: Generally acceptable for most procedures
For neuraxial anesthesia specifically, Factor XIII activity ≥50 IU/dL is required for mild bleeding history, and ≥80 IU/dL for severe bleeding history 4.
Common Pitfalls to Avoid
- Don't assume "low INR" means normal coagulation - verify actual values and clinical context
- Don't skip the mixing study - it's essential to differentiate factor deficiency from inhibitors 2
- Don't forget vitamin K deficiency - it's the most common acquired cause of common pathway abnormalities 3
- Don't rely solely on PT/aPTT for bleeding prediction - nearly half of PT/INR and aPTT variance remains unexplained by factor activity in some populations 6, 7
- Don't overlook medication history - heparin, warfarin, and DOACs all affect these tests differently 1
When to Suspect Specific Conditions
- Lupus anticoagulant: Prolonged aPTT with paradoxically normal or low bleeding risk, mixing study fails to correct 2, 3
- Factor XII deficiency: Markedly prolonged aPTT with NO bleeding history (Factor XII is not essential for hemostasis) 3
- Acquired hemophilia: New-onset bleeding in previously healthy individual, mixing study shows inhibitor pattern 1
The clinical bleeding history remains paramount - patients with prolonged coagulation tests but no bleeding history (e.g., Factor XII deficiency, lupus anticoagulant) require different management than those with true hemostatic defects 2, 3.